Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
RESHAPE LIFESCIENCES INC (RSLS) Stock Price & Overview
NASDAQ:RSLS • US76090R3093
Current stock price
3.92 USD
+0.72 (+22.5%)
At close:
3.22 USD
-0.7 (-17.86%)
After Hours:
The current stock price of RSLS is 3.92 USD. Today RSLS is up by 22.5%. In the past month the price increased by 37.54%. In the past year, price decreased by -98.49%.
RSLS Key Statistics
52-Week Range1.87 - 303.248
Current RSLS stock price positioned within its 52-week range.
1-Month Range1.87 - 4.65
Current RSLS stock price positioned within its 1-month range.
- Market Cap
- 81.262M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -212.11
- Dividend Yield
- N/A
RSLS Stock Performance
Today
+22.5%
1 Week
+45.19%
1 Month
+37.54%
3 Months
-37.58%
Longer-term
6 Months -93.27%
1 Year -98.49%
2 Years -99.71%
3 Years -99.35%
5 Years N/A
10 Years N/A
RSLS Stock Chart
RSLS Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to RSLS. When comparing the yearly performance of all stocks, RSLS is a bad performer in the overall market: 99.02% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
RSLS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RSLS. RSLS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RSLS Earnings
Next Earnings DateNov 12, 2025
Last Earnings DateAug 12, 2025
PeriodQ1 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
RSLS Forecast & Estimates
For the next year, analysts expect an EPS growth of 20% and a revenue growth 20% for RSLS
Analysts
Analysts43.33
Price TargetN/A
EPS Next Y20%
Revenue Next Year20%
RSLS Financial Highlights
Over the last trailing twelve months RSLS reported a non-GAAP Earnings per Share(EPS) of -212.11. The EPS increased by 93.64% compared to the year before.
Income Statements
Revenue(TTM)7.17M
Net Income(TTM)-3.46M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -53.42% | ||
| ROE | -281.54% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%114%
Sales Q2Q%-42.75%
EPS 1Y (TTM)93.64%
Revenue 1Y (TTM)-13.93%
RSLS Ownership
Ownership
Inst Owners0.73%
Shares20.73M
Float2.13M
Ins Owners0.06%
Short Float %N/A
Short RatioN/A
RSLS Industry Overview
RSLS operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.3
- Average Fwd P/E
- 27.4
- Average Debt/Equity
- 0.5
RSLS Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.59B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 155.452B | ||
| SYK | STRYKER CORP | 17.41 | 112.876B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 83.969B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.418B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 45.068B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.515B | ||
| RMD | RESMED INC | 16.7 | 29.867B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.847B | ||
| DXCM | DEXCOM INC | 20.18 | 23.611B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 16.047B | ||
| PEN | PENUMBRA INC | 63.83 | 12.792B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.354B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RSLS
Company Profile
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 17 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Company Info
IPO: 2016-10-06
RESHAPE LIFESCIENCES INC
1001 Calle Amanecer
San Clemente CALIFORNIA 92673 US
CEO: Andrew Rasdal
Employees: 17
Phone: 19494296680
RESHAPE LIFESCIENCES INC / RSLS FAQ
What does RSLS do?
ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 17 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
What is the current price of RSLS stock?
The current stock price of RSLS is 3.92 USD. The price increased by 22.5% in the last trading session.
Does RESHAPE LIFESCIENCES INC pay dividends?
RSLS does not pay a dividend.
What is the ChartMill technical and fundamental rating of RSLS stock?
RSLS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of RESHAPE LIFESCIENCES INC (RSLS) based on its PE ratio?
RESHAPE LIFESCIENCES INC (RSLS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-212.11).
Would investing in RESHAPE LIFESCIENCES INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RSLS.
What is RESHAPE LIFESCIENCES INC worth?
RESHAPE LIFESCIENCES INC (RSLS) has a market capitalization of 81.26M USD. This makes RSLS a Micro Cap stock.